AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.060
+0.020 (0.98%)
At close: Jul 14, 2025, 4:00 PM
2.080
+0.020 (0.97%)
After-hours: Jul 14, 2025, 4:00 PM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $203.82 million as of July 14, 2025. Its market cap has decreased by -48.85% in one year.
Market Cap
203.82M
Enterprise Value
45.90M
1-Year Change
-48.85%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $203.82M, a decrease of -76.50%. That is a compound annual growth rate of -15.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 204.80M | -24.04% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |